Patents by Inventor John Blebea

John Blebea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Opioid growth factor modulates angiogenesis
    Publication number: 20010046968
    Abstract: The present invention provides that an endogenous opioid peptide, OGF, inhibits angiogenesis in vivo via acting on OGF receptor. The present inventions also provides that opioid antagonist naltrexone and naltrexone stimulated blood vessel development. Therapeutic compositions and methods for modulating angiogenesis are provided.
    Type: Application
    Filed: March 22, 2001
    Publication date: November 29, 2001
    Inventors: Ian S. Zagon, John Blebea, Patricia J. McLaughlin